From a clinical point of view, the observation that diabetic subjects with HMGA1 gene defects might display also a decrease in FoxO1 protein expression supports the notion that patients with T2D who have these defects may have a different clinical course than other patients with T2D. Here, FOXO1 is linked to type 2 diabetes mellitus.